Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer

NCT01623102 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: cisplatin and gemcitabine combination with Bevacizumab
DRUG: Gemcitabine combined with cisplatin chemotherapy

Sponsor

Sichuan Cancer Hospital and Research Institute